Takaoka, Japan

Eitora Yamamura

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Toyama, JP (2014)
  • Takaoka, JP (2008 - 2019)

Company Filing History:


Years Active: 2008-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Eitora Yamamura: Innovator in Prostaglandin and RNA Technologies

Introduction

Eitora Yamamura is a notable inventor based in Takaoka, Japan. He has made significant contributions to the fields of biochemistry and molecular biology, particularly through his innovative patents. With a total of five patents to his name, Yamamura has focused on methods that enhance the production of important biological compounds.

Latest Patents

Yamamura's latest patents include a method for prostaglandin production and a novel double-stranded ribonucleic acid (dsRNA) for use as an adjuvant. The prostaglandin production method involves reacting an unsaturated fatty acid with cyclooxygenase in the presence of a reducing agent, allowing for high-yield production of prostaglandins. His dsRNA invention is characterized by a chain length that balances low toxicity with high functionality, making it suitable for use in immune potentiators and pharmaceutical products.

Career Highlights

Throughout his career, Eitora Yamamura has worked with prominent companies such as Kyowa Hakko Bio Co., Ltd. and Daiichi Fine Chemical Co., Ltd. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in biotechnological applications.

Collaborations

Yamamura has collaborated with esteemed colleagues, including Tetsuo Nakano and Noboru Fujimoto. These partnerships have fostered a creative environment that has led to the development of groundbreaking technologies.

Conclusion

Eitora Yamamura's contributions to the fields of prostaglandin production and RNA technology highlight his role as a significant innovator. His patents reflect a commitment to advancing scientific knowledge and improving biotechnological processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…